Artículo especial
Inmunoglobulina endovenosa en enfermedades neuromusculares. Actualización de la guía para su utilización
Intravenous immunoglobulin in neuromuscular diseases, guideline update for its use
Grupo de Trabajo de Enfermedades del Sistema Nervioso Periférico de la Sociedad Neurológica Argentina ◊
Leído
41980
Vecesse ha leído el artículo
3288
Total PDF
38692
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 149 | 12 | 161 |
| 2025 11 | 702 | 38 | 740 |
| 2025 10 | 660 | 26 | 686 |
| 2025 9 | 544 | 25 | 569 |
| 2025 8 | 535 | 45 | 580 |
| 2025 7 | 578 | 26 | 604 |
| 2025 6 | 596 | 19 | 615 |
| 2025 5 | 747 | 17 | 764 |
| 2025 4 | 569 | 31 | 600 |
| 2025 3 | 593 | 31 | 624 |
| 2025 2 | 532 | 25 | 557 |
| 2025 1 | 494 | 21 | 515 |
| 2024 12 | 372 | 14 | 386 |
| 2024 11 | 394 | 24 | 418 |
| 2024 10 | 407 | 16 | 423 |
| 2024 9 | 454 | 12 | 466 |
| 2024 8 | 360 | 19 | 379 |
| 2024 7 | 429 | 28 | 457 |
| 2024 6 | 377 | 25 | 402 |
| 2024 5 | 418 | 31 | 449 |
| 2024 4 | 318 | 26 | 344 |
| 2024 3 | 458 | 35 | 493 |
| 2024 2 | 430 | 24 | 454 |
| 2024 1 | 418 | 22 | 440 |
| 2023 12 | 393 | 33 | 426 |
| 2023 11 | 495 | 41 | 536 |
| 2023 10 | 586 | 60 | 646 |
| 2023 9 | 390 | 24 | 414 |
| 2023 8 | 379 | 20 | 399 |
| 2023 7 | 509 | 33 | 542 |
| 2023 6 | 558 | 58 | 616 |
| 2023 5 | 754 | 25 | 779 |
| 2023 4 | 520 | 20 | 540 |
| 2023 3 | 536 | 32 | 568 |
| 2023 2 | 376 | 27 | 403 |
| 2022 1 | 306 | 22 | 328 |
| 2022 12 | 279 | 39 | 318 |
| 2022 11 | 388 | 47 | 435 |
| 2022 10 | 411 | 30 | 441 |
| 2022 9 | 430 | 60 | 490 |
| 2022 8 | 364 | 51 | 415 |
| 2022 7 | 283 | 31 | 314 |
| 2022 6 | 334 | 36 | 370 |
| 2022 5 | 352 | 40 | 392 |
| 2022 4 | 264 | 41 | 305 |
| 2022 3 | 360 | 51 | 411 |
| 2022 2 | 307 | 17 | 324 |
| 2021 1 | 453 | 23 | 476 |
| 2021 12 | 349 | 37 | 386 |
| 2021 11 | 341 | 59 | 400 |
| 2021 10 | 415 | 60 | 475 |
| 2021 9 | 453 | 50 | 503 |
| 2021 8 | 747 | 50 | 797 |
| 2021 7 | 442 | 39 | 481 |
| 2021 6 | 509 | 36 | 545 |
| 2021 5 | 493 | 52 | 545 |
| 2021 4 | 1152 | 86 | 1238 |
| 2021 3 | 521 | 39 | 560 |
| 2021 2 | 468 | 31 | 499 |
| 2020 1 | 403 | 44 | 447 |
| 2020 12 | 418 | 51 | 469 |
| 2020 11 | 492 | 48 | 540 |
| 2020 10 | 191 | 38 | 229 |
| 2020 9 | 389 | 39 | 428 |
| 2020 8 | 407 | 38 | 445 |
| 2020 7 | 341 | 36 | 377 |
| 2020 6 | 359 | 72 | 431 |
| 2020 5 | 368 | 46 | 414 |
| 2020 4 | 489 | 70 | 559 |
| 2020 3 | 420 | 52 | 472 |
| 2020 2 | 439 | 40 | 479 |
| 2020 1 | 444 | 51 | 495 |
| 2019 12 | 384 | 46 | 430 |
| 2019 11 | 513 | 64 | 577 |
| 2019 10 | 513 | 45 | 558 |
| 2019 9 | 501 | 29 | 530 |
| 2019 8 | 256 | 31 | 287 |
| 2019 7 | 333 | 43 | 376 |
| 2019 6 | 524 | 60 | 584 |
| 2019 5 | 481 | 84 | 565 |
| 2019 4 | 336 | 32 | 368 |
| 2019 3 | 125 | 12 | 137 |
| 2019 2 | 171 | 10 | 181 |
| 2019 1 | 138 | 22 | 160 |
| 2018 12 | 87 | 9 | 96 |
| 2018 11 | 133 | 17 | 150 |
| 2018 10 | 180 | 34 | 214 |
| 2018 9 | 277 | 10 | 287 |
| 2018 8 | 213 | 15 | 228 |
| 2018 7 | 105 | 12 | 117 |
| 2018 6 | 127 | 7 | 134 |
| 2018 5 | 123 | 19 | 142 |
| 2018 4 | 89 | 5 | 94 |
| 2018 3 | 57 | 4 | 61 |
| 2018 2 | 34 | 0 | 34 |
| 2018 1 | 54 | 8 | 62 |
| 2017 12 | 49 | 4 | 53 |
| 2017 11 | 69 | 6 | 75 |
| 2017 10 | 61 | 9 | 70 |
| 2017 9 | 65 | 6 | 71 |
| 2017 8 | 72 | 19 | 91 |
| 2017 7 | 11 | 6 | 17 |
| 2017 6 | 0 | 3 | 3 |
Mostrar todo
